Note: Ingredients listed on restricted chemical lists
EC/CAS
9005-25-8
Name of the chemical
Starch
Concentration
N/A
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
N/A
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
General Information
Revision date
2025-12-01
Product name
Spironolactone Tablets 25 mg, 50 mg, and 100 mg
1.2.1 Relevant identified uses
Pharmaceutical product for the treatment of high blood pressure (hypertension)
Manufacturer Name
Annora Pharma Private Limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc.
Section 2
SECTION 2: Hazards identification
Precautionary statements
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P260 - Do not breathe dust/fume/gas/mist/vapors/spray P281 - Use personal protective equipment as required P308 + P313 - IF exposed or concerned: Get medical attention/advice P314 - Get medical attention/advice if you feel unwell P405 - Store locked up P501 - Dispose of contents/container in accordance with all local and national regulations
2.3 Other hazards
No data available Australian Hazard Classification
Hazardous Ingredients
Non-Dangerous Goods (NOHSC)
